Literature DB >> 8559364

Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese.

Y T Mak1, H Chiu, J Woo, R Kay, Y S Chan, E Hui, K H Sze, C Lum, T Kwok, C P Pang.   

Abstract

We studied the apolipoprotein E (apoE) allele frequencies in 65 Chinese patients with late-onset Alzheimer's disease (AD) and 82 age- and sex-matched controls. The apoE epsilon 4 allele frequency was significantly higher in the AD group than in the control group (0.169 versus, p < 0.01). There were five homozygotes for epsilon 4 in the AD group but none among the controls. The odds ratio for AD was 1.6 for epsilon 4 heterozygotes. The age at onset was lower in the presence of the epsilon 4 allele and higher with the epsilon 2 allele, although neither of these differences reached statistical significance. The association between apoE alleles and AD previously reported in Caucasian populations was also present in this reports of lower prevalence of AD compared with the prevalence of multi-infarct dementia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8559364     DOI: 10.1212/wnl.46.1.146

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Selenium level and cognitive function in rural elderly Chinese.

Authors:  Sujuan Gao; Yinlong Jin; Kathleen S Hall; Chaoke Liang; Frederick W Unverzagt; Rongdi Ji; Jill R Murrell; Jingxiang Cao; Jianzhao Shen; Feng Ma; Janetta Matesan; Bo Ying; Yibin Cheng; Jianchao Bian; Ping Li; Hugh C Hendrie
Journal:  Am J Epidemiol       Date:  2007-01-31       Impact factor: 4.897

Review 2.  Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.

Authors:  Morteza Abyadeh; Kurosh Djafarian; Fatemeh Heydarinejad; Shahab Alizadeh; Sakineh Shab-Bidar
Journal:  J Mol Neurosci       Date:  2019-08-23       Impact factor: 3.444

Review 3.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.

Authors:  Amy R Borenstein; James A Mortimer; Gerard D Schellenberg; Charles DeCarli; Cathleen Copenhaver; Douglas Galasko; David P Salmon; Ronald Petersen
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-02-08       Impact factor: 2.035

5.  Association of Pro/Anti-inflammatory Cytokine Gene Polymorphisms with Benign Prostate Hyperplasia Risk.

Authors:  Pravin Kesarwani; Rama D Mittal
Journal:  Indian J Clin Biochem       Date:  2010-09-14

6.  High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population.

Authors:  Afef Achouri Rassas; Hela Mrabet Khiari; Sondes Hadj Fredj; Safa Sahnoun; Hend Batti; Nouria Oudiaa Zakraoui; Aroua Cherif; Nadia Anane; Nadia Ben Ali; Taieb Messaoud; Amel Mrabet
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

Review 7.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

8.  Apolipoprotein E polymorphisms and primary glaucoma in Saudis.

Authors:  Najwa Mohammed Al-Dabbagh; Nourah Al-Dohayan; Misbahul Arfin; Mohammad Tariq
Journal:  Mol Vis       Date:  2009-05-04       Impact factor: 2.367

Review 9.  ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

Authors:  Arlene M Manelli; W Blaine Stine; Linda J Van Eldik; Mary Jo LaDu
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 10.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.